Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
Keyword(s):
Keyword(s):
2015 ◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19076-e19076
Keyword(s):
2015 ◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 48
(18)
◽
pp. 3378-3385
◽
2011 ◽
Vol 42
(8)
◽
pp. 669-676
◽
Keyword(s):
Keyword(s):